BioSpace News Archive

Pancreatic cancer cells use a normal waste removal process to hide tags on their surfaces that would otherwise let the immune system destroy them, a new study finds.

Neocis, Inc., the manufacturer of the Yomi Dental Robotics System, is proud to announce that several of their employees are volunteering their personal time and sharing their professional expertise to help The Ventilator Project.

In terms of revenue, the global sepsis therapeutics market is projected to expand at a CAGR of 7.5% during the forecast period due to numerous factors, about which, TMR offers comprehensive insights and forecasts in the global sepsis therapeutics market report.

According to the report, the global sterilization services market was valued at US$ 3.1Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Sterilization service providers offer sterilization of various supplies such as medical devices, instruments, pharmaceuticals, and other products.

Physician group stands up technology solution to maintain continuity of care for at-risk patients [22-April-2020] DENVER , April 22, 2020 /PRNewswire/ -- Nephrology Care Alliance (NCA), a nephrologist-led organization that seeks to empower physicians to succeed in a changing health care environment, recently formalized a collaboration with Mend, a leading tele

AntiCancer Inc. has announced that it has established a fully owned subsidiary company, CoronaCure LLC, in order to develop its novel therapeutic for COVID-19..

Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020

REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, provided additional long-term data from the ongoing Phase I/IIa trial of RGX-314 for the treatment of wet age-related macular degeneration.

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the first quarter ended March 31, 2020.

Tests Assist in Confirming the Presence of Antibodies to the Virus that Causes COVID-19